SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Starship Flight 14 reaching orbit and deploying 26 Starlink V3 satellites is the main focus, with bulls viewing the mission as a step toward expanding Starlink capacity and commercial potential. The reaction is divided: engine trouble shortened the flight and fueled criticism of the mission and the stocks valuation, while supporters call the deployment a major milestone despite the share-price decline.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Attention centers on Summits FDA review of ivonescimab, with traders debating regulatory risk after reports of weaker progression-free-survival results in a Chinese trial label. Some argue the concern is overstated because no detailed figures were disclosed and point to other positive trial results and insider buying; others worry about the FDAs evidence requirements and potential dilution.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation silicon-carbide power semiconductors is drawing attention as a sign of technology and domestic-manufacturing validation. Many traders are bullish and discussing a possible short squeeze, while others note that the awards financial terms are undisclosed and near-term revenue is uncertain.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs review of a 737 MAX software glitch has delayed MAX 10 certification, and Southwest and United reportedly do not want deliveries with the affected software. Traders are split between calling the issue fixable and the selloff excessive, and viewing it as another quality and regulatory setback that could extend delays.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak surged after Phase 3 DAYBREAK results showed both experimental treatments met their primary goals in wet AMD, with vision outcomes non-inferior to Eylea and Zenkuda showing potential for longer dosing intervals; the company plans an FDA filing for Zenkuda. Traders celebrated the clinical progress and discussed short covering, while others questioned the rallys sustainability and flagged potential financing and dilution needs.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

A prolonged selloff and weak share-price performance are driving discussion, with many traders frustrated that the stock has struggled despite reported business growth. The community is divided over whether dilution and insider selling, short pressure, and higher rates are weighing on shares, while bulls point to SoFis growth and Mastercard stablecoin-settlement deal as strengths the market may be overlooking.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Attention centers on the proposed Mesabi Metallics steel complex in Iowa, which traders fear could add competing supply and pressure Cleveland-Cliffs; many question whether the project will secure financing or be completed. Concern about Hamilton production cuts adds to the bearish discussion, while bulls argue the Iowa project is years away and point to strong steel prices.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

XERS is drawing attention after a sharp run toward double digits, with traders speculating about large-scale accumulation and sympathy buying after a Phase 3-driven surge in another biotech. Others cite Recorlevs growth and the anticipated XP-8121 Phase 3 program, while cautioning that no new Xeris-specific catalyst is confirmed and that further progress may be needed to sustain the move.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Attention is centered on Rivians upcoming Q3 production and delivery update, with traders watching whether the R2 ramp and planned second shift can support growth and company guidance. Bulls point to strong R2 interest, while skeptics cite supplier constraints, execution risks and ongoing losses, debating whether the results will validate the ramp or disappoint.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp, high-volume rally is being linked by traders to Hederas enterprise AI activity involving IBM and NVIDIA, though some say no clear fresh catalyst explains the move. The reaction is broadly bullish, but traders are debating whether momentum can continue or whether profit-taking and a pullback will follow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amprius award of up to a federal defense grant to expand U.S. production of high-energy batteries for drones is the main catalyst, with bullish traders viewing it as strategic validation and a path to greater capacity. Others caution that the expansion is years away and does not itself confirm customer orders or near-term revenue; the stocks sharp fade after an initial rally has fueled debate over the news immediate financial impact.

Amprius Secures $75 Million Grant for American High-Energy Density Battery Production

Amprius Technologies (Amprius or the Company) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $75 million from the U.S. Department of War (DoW) to retrofit an existing domestic production line from EV batteries to high-energy density cells for unmanned aerial...

Amprius Introduces SiCore500 High Energy Density Cells for Unmanned Aviation

Amprius Technologies ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced a new 500 Wh/kg SiCore cell, designed for long-endurance aviation. The cell delivers 500 Wh/kg at a 1C continuous discharge rate and can be produced on conventional...

Amprius Sets September 2026 Events Schedule

Amprius Technologies, Inc. (Amprius or the Company) (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced its schedule for September appearances and activities.Commercial UAV Expo 2026Date: September 1-3, 2026Location: Caesars Forum; Las Vegas, NVEvent Details: Amprius will...

AMPX Q2 Earnings Call Highlights Higher Guidance and Drone Demand

Amprius raises 2026 revenue and margin guidance as drone demand, European sales and manufacturing economics strengthen visibility.

Amprius Technologies (AMPX) Reports Q2 Loss, Beats Revenue Estimates

Amprius (AMPX) delivered earnings and revenue surprises of 0.00% and +17.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Amprius Technologies Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced financial results for the second quarter ended June 30, 2026, and discussed recent business developments. Revenue for the second quarter of 2026 was $34.0 million...

Amprius Technologies Set to Report Q2 Earnings: What's in the Cards?

AMPX heads into Q2 results with revenues expected to surge 92.6% y/y, fueled by customer wins and rising SiCore battery adoption.

Duos Technologies Group, Inc. (DUOT) Moves 5.8% Higher: Will This Strength Last?

Duos Technologies Group, Inc. (DUOT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Amprius Technologies Sets Upcoming Conference Schedule

Amprius Technologies, Inc. ("Amprius"), (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced that it will participate in the upcoming conferences:Canaccord Genuity 46th Annual Growth ConferenceDate: Aug. 11-12, 2026Location: InterContinental Boston; Boston, MAEvent...

Amprius Technologies Becomes Oversold (AMPX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Amprius Technologies (NYSE: AMPX) is at the forefront of transforming electric mobility with its revolutionary Silicon Anode lithium-ion battery. The company is powering a new era, offering a drop-in replacement for conventional lithium-ion batteries while delivering up to 80% higher energy density. Leveraging its patented silicon anode platform, the company’s commercially proven batteries deliver unmatched performance – ultra-high energy density, high power density, extreme fast charge rate capability, wide operating temperature, and long cycle life.

Amprius Technologies Inc

Why Did Amprius Stock Surge Over 11% Today?

Equity

Extremely Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

Stocktwits Polls

Investors are buzzing over a $75 million government grant aimed at scaling drone battery production for domestic defense needs.

Traders are venting frustration over intraday price dips and alleged algorithmic manipulation following the positive grant news.

Long-term bulls are focusing on high-density silicon-anode tech as a core component for future robotics, aviation, and defense markets.

The sentiment is shifting toward upcoming earnings as a potential catalyst for sustained price momentum above key resistance levels.

$AMPX dude we are holding for long term. Noone gives a shit about pump and dumps when we know it is clearly a 30+ dollar stock. Profitability is also in the corner which is a very important factor. If you are selling coz you see a 7% pump then you are just a gambler and should move to wallstreetbets lmao.

Bokehmon

$AMPX this is the best battery company in the market .
I’ve been loading for 2 years, and will keep loading

Jumpingfalldown

$AMPX 138m float: Amprius Secures $75 Million Grant for American High-Energy Density Battery Production

GreatStockPix.com

$AMPX I'm still confused here, so if AMPX suddenly LOST the $75,000,000.00 grant, the stock would then REBOUND, right?

Stuart Griffin Burgh

$AMPX read the tea leaves. Gov provided a grant so they can expedite their batteries for drones. 
That should give you confidence in holding

Patrick Khalatians

$AMPX The U.S. government isn't just handing AMPX pocket change—Uncle Sam is straight-up bankrolling domestic production! Under their $75 million non-dilutive award (Project acCELLerate), the DoD is funding high-volume, domestic manufacturing of high-energy silicon-anode battery cells tailored for military drones. No cost share required, $22M already obligated upfront, and strict NDAA compliance locked in.

This isn't just a grant; it's the official stamp of approval to build out a secure U.S. manufacturing base. When the military installs your factory footprint, massive defense supply orders follow right behind it. Good luck to the short sellers trying to squeeze a company whose primary backer is the United States Department of War!

Khalid Jamil

$AMPX Stocks fluctuate over days, weeks and months. Sometimes hype pushes a share price far ahead of current fundamentals. Then sentiment reverses and a small-cap stock can fall much further than changes in the underlying business justify. 
 
That is why I find daily price watching largely useless. 
 
What matters to me is whether the COMPANY keeps delivering: execution against promises, business model, addressable markets, future demand, manufacturing strategy, sales channels, leadership, margins and CapEx. 
 
That seems to be the common thread among successful long-term investors like Buffett and Lynch: conviction comes from understanding the underlying asset, not reacting to every movement in its quoted price. 
 
From my own research, Amprius continues to check the boxes that matter to me. I care far more about where the business is going than what someone happens to bid for the shares today.

Onkel Sort

$AMPX if anyone here still believes that MM  "don't" use "algos"to screw this stock in particular,  please go get your head checked.  
The most blatant use of algos I have been.

Hershy

$AMPX It's ok. You can't unrelease the news shorts. The price will catch up to it. Tread carefully.

John Crawford

$AMPX Amprius Technologies granted $75M from DoW for battery production 
 
Amprius Technologies has been awarded a grant of up to $75M from the U.S. Department of War to retrofit an existing domestic production line from EV batteries to high-energy density cells for unmanned aerial systems. The grant was awarded through the DoW's Industrial Base Analysis and Sustainment program, which funds domestic manufacturing capabilities critical to national defense. The primary objective of this award is to establish high-volume, commercially viable U.S. manufacturing for advanced battery systems that power unmanned aerial systems - Group 1, 2, and 3 drones. Amprius plans to use the funds to reconfigure an existing U.S.-based electric vehicle battery production line operated by a major South Korean manufacturer.  
 
At completion, planned for early 2028, the line is expected to have the capacity to produce 12 million Amprius cells annually. These cells are intended to meet the domestic sourcing requirements of the National Defense Authorization Act. The conversion project is expected to cost approximately $100M, including in-kind investments from Amprius and its South Korean partner. The modified line expands Amprius' existing contract manufacturing relationships and significantly increases the ability of the company to provide NDAA-compliant pouch cells for key customers at scale. This project adds to the company's global manufacturing network in China, South Korea, and the United States.

DonCorleone77

$AMPX I learned something today , getting  a 75 million dollar grant is negative news lol

Sonny sandhu

$AMPX  
this isn't a broken-story stock — it's a stock where the business is executing well, but the multiple has compressed anyway.  
 
That lines up exactly with the sector read: QuantumScape, Solid Power, Enovix, SES are all getting hit by the same rate-driven de-rating of long-duration growth names, even the ones (like AMPX) posting real beats.  
 
AMPX has actually held up better than most of that cohort precisely because it has real, accelerating revenue. 
 
So, HODL guys.

Jonathan

I have great news to share this morning regarding two of my drone/EVTOL high density batter makers:

$AMPX Was ordered a $75M grant from the Feds to retrofit a production line from EVs to high density EVTOL applications. 

Meanwhile, $SES has just officially received its ISO NDAA designation for its new 1 mil cell/year battery factory. 

What a great way to kick the week off 🦵🔋💥

Indpndtqst

$AMPX 
wait for the volume spike.

It’s that simple.

Bullish confirmation: a green (up) day on the daily chart where volume noticeably expands relative to the recent thin bars — that would signal real buying stepping in, not just sellers stepping back.

$AMPX cashed out . Now time to start adding more again.

This is one of the better “buy and hold” small cap stocks right now .

$AMPX The build up begins 💪

DroneX Trade Show & Conference (Sept 29–30, 2026 – London, UK): Chief Business Officer Ronnie Tao is presenting on commercial drone ranges. Contract announcements or commercial pilot updates often drop during or adjacent to defense/drone trade shows.  
Evercore ADAS, AV & AI Forum (Sept 29, 2026 – New York, NY): Management will be conducting one-on-one investor meetings, which can generate fresh research updates or retail interest.  🤞

$AMPX love buying this under $10!

This is one of the easiest “buy and hold” small cap stocks on the market.

2x + from here as soon as the market gets better.

$AMPX let the algos settle down, and remain patient.  
In long term these prices are a steal. That's what you need, long term vision and patience

$AMPX Well well well. The catalyst we've been waiting for. One of them anyway. Like I said when it was below 10, buying was a no brainer. Let's go!

$AMPX 
 
+8.7% premarket to ~10.60 on a 75 million grant from the Defense Department's IBAS program to convert an existing EV battery line to high-energy-density cells for drones. 
 
The non-dilutive part matters: the grant covers ~75% of the ~100 million conversion cost. Completion early 2028, capacity 12 million Amprius cells a year. 
 
The real prize is the NDAA angle. The cells are meant to meet domestic-sourcing requirements under the National Defense Authorization Act, and CEO Tom Stepien called it "a primary source of domestic, NDAA-compliant battery production." 
 
Grant money, not a purchase order. But it makes Amprius one of the first funded candidates for the NDAA-compliant drone-battery lane.

AMPX Amprius Technologies Inc